Drug Profile
Rosuvastatin companion diagnostic - BG Medicine
Alternative Names: ARCHITECT Galectin-3; BGM Galectin-3; VIDAS Galectin-3Latest Information Update: 26 Sep 2013
Price :
$50
*
At a glance
- Originator Maastricht University
- Developer BG Medicine; bioMerieux SA
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acute heart failure; Chronic heart failure
Most Recent Events
- 23 Sep 2013 Pharmacodynamics data from a clinical study in Heart failure released by BG Medicine
- 14 May 2012 BG Medicine files a 510(k) application to extend the approved labelling indication to include members of the general adult population who are at risk of developing heart failure based on elevated galectin-3 levels
- 14 May 2012 Efficacy data from a substudy of the phase III CORONA trial in Heart failure released by BG Medicine